Activated partial thromboplastin time: New tricks for an old dogma

Seminars in Thrombosis and Hemostasis

Volumn 34, Issue 7, 2008, Pages 604-611

  Lippi, Giuseppe ^a,c   Favaloro, Emmanuel J ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Activated partial thromboplastin time; Clotting assay; Factor V; Hemophilia; Therapy

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; C REACTIVE PROTEIN; D DIMER; HEPARIN; LOW DENSITY LIPOPROTEIN; LUPUS ANTICOAGULANT; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

BLOOD CLOTTING; BLOOD CLOTTING TIME; CLINICAL LABORATORY; DISSEMINATED INTRAVASCULAR CLOTTING; HUMAN; HYPERCOAGULABILITY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; THROMBOPHILIA; VENOUS THROMBOEMBOLISM; WAVEFORM;

BLOOD COAGULATION; BLOOD COAGULATION FACTORS; HUMANS; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 58149089640     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0028-1104539     Document Type: Review

References (41)

1. Lippi G, Franchini M, Guidi GC. Diagnostic approach to inherited bleeding disorders. Clin Chem Lab Med 2007; 45:2-12
2. MacFarlane RG. An enzyme cascade in the blood clotting mechanism and its function as a biochemical amplifier. Nature 1964;202:498-499
3. Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science 1964;145:1310-1312
4. Langdell RD, Wagner RH, Brinkhous KM. Effect of anti-hemophilic factor on one-stage clotting tests: a presumptive test for hemophilia and a simple one-stage anti-hemophilic factor assay procedure. J Lab Clin Med 1953;41:637-647
5. Proctor RR, Rapaport SI. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Pathol 1961;36:212-219
6. White GC. The partial thromboplastin time: defining an era in coagulation. J Thromb Haemost 2003;1:2267-2270
7. Clinical and Laboratory Standards Institute. Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays; Approved Guideline H21-A5, 5th ed. Wayne, PA: CLSI; 2008
8. Manzato F, Mengoni A, Grilenzoni A, Lippi G. Evaluation of the activated partial thromboplastin time (APTT) sensitivity to heparin using five commercial reagents: implications for therapeutic monitoring. Clin Chem Lab Med 1998;36:975-980
9. NCCLS. One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test; Approved Guideline. NCCLS document H47-A. Wayne, PA: National Committe on Clinical Laboratory Standards; 1996
10. Lippi G, Franchini M, Montagnana M, Guidi GC. Coagulation testing in pediatric patients: the young are not just miniature adults. Semin Thromb Hemost 2007;33:816-820
11. Favaloro EJ, Lippi G, Adcock D. Preanalytical and postanalytical variables in haemostasis: the leading causes of diagnostic error? Semin Thromb Hemost 2008;34:612-634
12. Lippi G, Franchini M, Brazzarola P, Manzato F. Preoperative screening: the rationale of measuring APTT in risk assessment. Haematologica 2001;86:328
13. Shetty S, Ghosh K, Mohanty D. Comparison of four commercially available activated partial thromboplastin time reagents using a semi-automated coagulometer. Blood Coagul Fibrinolysis 2003;14:493-497
14. Tripodi A. Laboratory testing for lupus anticoagulants: diagnostic criteria and use of screening, mixing and confirmatory studies. Semin Thromb Hemost 2008;34:585-592
15. Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L. Cross-laboratory audit of normal reference ranges and assessment of ABO-blood group, gender and age on detected levels of plasma coagulation factors. Blood Coagul Fibrinolysis 2005;16:597-605
16. Tripodi A, Mannucci PM. Activated partial thromboplastin time (APTT). New indications for an old test? J Thromb Haemost 2006;4:750-751
17. Korte W, Clarke S, Lefkowitz JB. Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism. Am J Clin Pathol 2000;113:123-127
18. Ten Boekel E, Böck M, Vrielink GJ, Liem R, Hendriks H, de Kieviet W. Detection of shortened activated partial thromboplastin times: an evaluation of different commercial reagents. Thromb Res 2007;121:361-367
19. McKenna R, Bachmann F, Miro-Quesada M. Thromboembolism in patients with abnormally short activated thromboplastin time. Thromb Haemost 1977;38:893-899
20. Reddy NM, Hall SW, MacKintosh FR. Partial thromboplastin time. Prediction of adverse events and poor prognosis by low abnormal values. Arch Intern Med 1999;159:2706-2710
21. Tripodi A, Chantarangkul V, Martinelli I, Bucciarelli P, Mannucci PM. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood 2004;104:3631-3634
22. Hron G, Eichinger S, Weltermann A, Quehenberger P, Halbmayer WM, Kyrle PA. Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time. J Thromb Haemost 2006;4:752-756
23. Legnani C, Mattarozzi S, Cini M, Cosmi B, Favaretto E, Palareti G. Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal. Br J Haematol 2006;134:227-232
24. Ten Boekel E, de Kieviet W, Bartels PC. Subjects with a shortened activated partial thromboplastin time show increased in-hospital mortality associated with elevated D-dimer, C-reactive protein and glucose levels. Scand J Clin Lab Invest 2003;63:441-448
25. Bick RL. Disseminated intravascular coagulation: pathophysiological mechanisms and manifestations. Semin Thromb Hemost 1998;24:3-18
26. Ten Boekel E, Bartels P. Abnormally short activated partial thromboplastin times are related to elevated plasma levels of TAT, F1 + 2, D-dimer and FVIII:C. Pathophysiol Haemost Thromb 2002;32:137-142
27. Mansvelt EP, Laffan M, McVey JH, Tuddenham EG. Analysis of the F8 gene in individuals with high plasma factor VIII: C levels and associated venous thrombosis. Thromb Haemost 1998;80:561-565
28. Madi AM, Greci LS, Nawaz H, Katz DL. The activated partial thromboplastin time in early diagnosis of myocardial infarction. Blood Coagul Fibrinolysis 2001;12:495-499
29. Downey C, Kazmi R, Toh CH. Novel and diagnostically applicable information from optical waveform analysis of blood coagulation in disseminated intravascular coagulation. Br J Haematol 1997;98:68-73
30. Downey C, Kazmi R, Toh CH. Early identification and prognostic implications in disseminated intravascular coagulation through transmittance waveform analysis. Thromb Haemost 1998;80:65-69
31. Nesheim M, Samis J, Walker J, et al. Lipoprotein-complexed C-reactive protein and the biphasic transmittance waveform in critically ill patients. Blood Rev 2002;16(Suppl 1):S15-S22
32. 2+-dependent complex of C-reactive protein with very low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation. Blood 2002;100:2522-2529
33. Matsumoto T, Wada H, Nishioka Y, et al. Frequency of abnormal biphasic aPTT clot waveforms in patients with underlying disorders associated with disseminated intravascular coagulation. Clin Appl Thromb Hemost 2006;12:185-192
34. Bakhtiari K, Meijers JC, de Jonge E, Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004;32:2416-2421
35. Toh CH, Ticknor LO, Downey C, Giles AR, Paton RC, Wenstone R. Early identification of sepsis and mortality risks through simple, rapid clot-waveform analysis. Implications of lipoprotein-complexed C reactive protein formation. Intensive Care Med 2003;29:55-61
36. Zakariah AN, Cozzi SM, Van Nuffelen M, Clausi CM, Pradier O, Vincent JL. Combination of biphasic transmittance waveform with blood procalcitonin levels for diagnosis of sepsis in acutely ill patients. Crit Care Med 2008;36:1507-1512
37. Chopin N, Floccard B, Sobas F, et al. Activated partial thromboplastin time waveform analysis: a new tool to detect infection? Crit Care Med 2006;34:1654-1660
38. Dempfle C-E, Borggrefe M. The hidden sepsis marker: aPTT waveform analysis. Thromb Haemost 2008;100:9-10
39. Hussain N, Hodson D, Marcus R, Baglin T, Luddington R. The biphasic transmittance waveform: an early marker of sepsis in patients with neutropenia. Thromb Haemost 2008;100:146-148
40. Kasuda S, Tanaka I, Shima M, et al. Effectiveness of factor VIII infusions in haemophilia A patients with high responding inhibitors. Haemophilia 2004;10:341-346
41. Shima M. Understanding the hemostatic effects of recombinant factor VIIa by clot wave form analysis. Semin Hematol 2004;41:125-131